Leyla Punzalan
Family · Hollywood, FLNPI 1730563065
Payments from drug & device makers
Across 300 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- Mylan Specialty L.p.$366
- ANI Pharmaceuticals, Inc.$356
- Mallinckrodt Hospital Products Inc.$293
- Insmed, Inc.$234
- plus $2K from 35 others
What the payments were for
- Food & beverage$5,875100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 74 | $1,239 |
| AstraZeneca | 54 | $1,036 |
| Mylan Specialty L.p. | 14 | $366 |
| ANI Pharmaceuticals, Inc. | 17 | $356 |
| Mallinckrodt Hospital Products Inc. | 16 | $293 |
| Insmed, Inc. | 11 | $234 |
| Boehringer Ingelheim | 10 | $219 |
| Sanofi | 8 | $210 |
| Novo Nordisk | 12 | $200 |
| Johnson & Johnson | 9 | $158 |
| United Therapeutics Corporation | 7 | $144 |
| Exact Sciences | 6 | $114 |
| Viatris Specialty LLC | 5 | $104 |
| Travere Therapeutics, Inc. | 1 | $97 |
| Pfizer | 5 | $92 |
| Merck | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| Phadia US Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 2 | $64 |
| Advanced Respiratory, Inc | 3 | $64 |
| Amarin Pharma, Inc. | 3 | $58 |
| Novartis | 3 | $58 |
| Amgen | 3 | $57 |
| Grifols USA, LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Verona Pharma, Inc. | 2 | $35 |
| AbbVie | 2 | $32 |
| VBI Vaccine (delaware) Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $27 |
| Inogen, Inc. | 1 | $26 |
| Bayer | 1 | $20 |
| Electromed, Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $18 |
| Pulmonx Corporation | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Eisai Inc. | 1 | $12 |
How this compares
$5,875 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 117 | $86,060 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $26,188 |
| OzempicSemaglutide | 25 | $26,020 |
| JardianceEmpagliflozin | 16 | $24,734 |
| SymbicortBudesonide/Formoterol Fumarate | 38 | $10,307 |
| Spiriva RespimatTiotropium Bromide | 16 | $8,337 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $6,190 |
| VascepaIcosapent Ethyl | 13 | $5,187 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 202 | $4,778 |
| Wixela InhubFluticasone Propion/Salmeterol | 31 | $2,787 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $1,796 |
| Fluticasone Propionate | 96 | $1,377 |
| Ventolin HfaAlbuterol Sulfate | 25 | $1,358 |
| Rosuvastatin Calcium | 57 | $1,003 |
| Atorvastatin Calcium | 107 | $861 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $1,239 | $92,250129 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,036 | $36,49477 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $219 | $33,07132 claims |
| Novo NordiskOzempic | $200 | $26,02025 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $356 | $36716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Hollywood
- Marisol RiveraHollywood$65K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.